Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory | 4 | 2018 | 227 | 1.270 |
Why?
|
| Speech Perception | 4 | 2016 | 73 | 1.030 |
Why?
|
| Hypertension | 2 | 2021 | 758 | 0.860 |
Why?
|
| Visual Perception | 4 | 2016 | 334 | 0.700 |
Why?
|
| Noncommunicable Diseases | 1 | 2021 | 7 | 0.670 |
Why?
|
| Phonetics | 3 | 2010 | 35 | 0.590 |
Why?
|
| Aging | 2 | 2013 | 727 | 0.540 |
Why?
|
| Association Learning | 1 | 2018 | 38 | 0.530 |
Why?
|
| Chronic Disease | 1 | 2021 | 962 | 0.530 |
Why?
|
| Speech Acoustics | 2 | 2010 | 22 | 0.530 |
Why?
|
| Sound | 1 | 2017 | 24 | 0.520 |
Why?
|
| Color | 1 | 2017 | 80 | 0.500 |
Why?
|
| Speech | 1 | 2016 | 90 | 0.470 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 190 | 0.440 |
Why?
|
| Life Expectancy | 1 | 2013 | 91 | 0.390 |
Why?
|
| Memory Disorders | 1 | 2013 | 72 | 0.370 |
Why?
|
| Crime | 1 | 2013 | 38 | 0.370 |
Why?
|
| Cognition | 1 | 2017 | 627 | 0.370 |
Why?
|
| Students | 1 | 2013 | 177 | 0.360 |
Why?
|
| Terminal Care | 1 | 2013 | 146 | 0.350 |
Why?
|
| Empathy | 1 | 2013 | 149 | 0.350 |
Why?
|
| Young Adult | 7 | 2020 | 6937 | 0.330 |
Why?
|
| Hospitals, District | 2 | 2021 | 2 | 0.330 |
Why?
|
| Uganda | 2 | 2021 | 46 | 0.330 |
Why?
|
| Auditory Pathways | 1 | 2010 | 35 | 0.320 |
Why?
|
| Cues | 2 | 2010 | 186 | 0.300 |
Why?
|
| Rural Population | 2 | 2021 | 170 | 0.300 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 7072 | 0.280 |
Why?
|
| Learning | 1 | 2010 | 292 | 0.260 |
Why?
|
| Age Factors | 3 | 2018 | 1907 | 0.240 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 453 | 0.230 |
Why?
|
| Quality of Life | 1 | 2013 | 1783 | 0.220 |
Why?
|
| Acoustic Stimulation | 2 | 2017 | 130 | 0.200 |
Why?
|
| Adult | 10 | 2021 | 27949 | 0.200 |
Why?
|
| Adolescent | 5 | 2018 | 9612 | 0.190 |
Why?
|
| Aged | 6 | 2021 | 20472 | 0.190 |
Why?
|
| Male | 9 | 2021 | 44582 | 0.180 |
Why?
|
| Photic Stimulation | 2 | 2017 | 509 | 0.180 |
Why?
|
| Female | 14 | 2021 | 48781 | 0.180 |
Why?
|
| Humans | 22 | 2021 | 93613 | 0.170 |
Why?
|
| Community Health Workers | 1 | 2021 | 36 | 0.160 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2020 | 5 | 0.160 |
Why?
|
| Personnel Turnover | 1 | 2020 | 11 | 0.160 |
Why?
|
| Knowledge | 1 | 2020 | 30 | 0.160 |
Why?
|
| Attention | 1 | 2003 | 411 | 0.150 |
Why?
|
| Middle Aged | 5 | 2021 | 27623 | 0.150 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 163 | 0.150 |
Why?
|
| Risk | 1 | 2020 | 657 | 0.140 |
Why?
|
| Neoplasms | 1 | 2013 | 3170 | 0.140 |
Why?
|
| Cohort Effect | 1 | 2017 | 7 | 0.130 |
Why?
|
| Semantics | 1 | 2017 | 55 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2021 | 896 | 0.130 |
Why?
|
| Mental Recall | 1 | 2018 | 172 | 0.120 |
Why?
|
| Judgment | 1 | 2013 | 69 | 0.100 |
Why?
|
| Reaction Time | 1 | 2013 | 317 | 0.090 |
Why?
|
| Psychoacoustics | 1 | 2010 | 9 | 0.080 |
Why?
|
| Digestive System | 1 | 1990 | 40 | 0.080 |
Why?
|
| Audiometry | 1 | 2010 | 12 | 0.080 |
Why?
|
| Signal Detection, Psychological | 1 | 2010 | 19 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 543 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1989 | 100 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2010 | 494 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 1989 | 602 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 1989 | 344 | 0.060 |
Why?
|
| Sound Spectrography | 1 | 2003 | 19 | 0.050 |
Why?
|
| Crohn Disease | 1 | 1990 | 808 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 1989 | 545 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 1077 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 1989 | 797 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 1993 | 2368 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 1989 | 2017 | 0.030 |
Why?
|
| Chordoma | 1 | 1993 | 42 | 0.020 |
Why?
|
| Sacrum | 1 | 1993 | 83 | 0.020 |
Why?
|
| Abetalipoproteinemia | 1 | 1991 | 2 | 0.020 |
Why?
|
| Jugular Veins | 1 | 1992 | 65 | 0.020 |
Why?
|
| Cryopreservation | 1 | 1992 | 71 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 1991 | 36 | 0.020 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 1991 | 6 | 0.020 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 1991 | 8 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1990 | 92 | 0.020 |
Why?
|
| Duodenum | 1 | 1990 | 110 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1991 | 145 | 0.020 |
Why?
|
| Esophagus | 1 | 1990 | 113 | 0.020 |
Why?
|
| Stomach | 1 | 1990 | 113 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 1990 | 98 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1990 | 356 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1992 | 242 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 124 | 0.020 |
Why?
|
| Liver | 2 | 1991 | 1207 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1990 | 124 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1991 | 310 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1990 | 160 | 0.020 |
Why?
|
| Adenofibroma | 1 | 1989 | 5 | 0.020 |
Why?
|
| Cystadenocarcinoma | 1 | 1989 | 12 | 0.020 |
Why?
|
| Aneuploidy | 1 | 1989 | 59 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1990 | 292 | 0.020 |
Why?
|
| Urethral Diseases | 1 | 1989 | 14 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1990 | 350 | 0.020 |
Why?
|
| Diverticulum | 1 | 1989 | 44 | 0.020 |
Why?
|
| Esophageal Diseases | 1 | 1988 | 25 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1990 | 356 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1990 | 260 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1989 | 572 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1989 | 505 | 0.020 |
Why?
|
| Barrett Esophagus | 1 | 1988 | 94 | 0.020 |
Why?
|
| Gene Expression | 1 | 1991 | 1304 | 0.020 |
Why?
|
| Biopsy | 1 | 1990 | 1177 | 0.020 |
Why?
|
| Carcinoma | 1 | 1989 | 439 | 0.010 |
Why?
|
| Colon | 1 | 1989 | 540 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1990 | 3833 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 2543 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1989 | 1173 | 0.010 |
Why?
|
| Prognosis | 1 | 1989 | 3915 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2002 | 164 | 0.010 |
Why?
|
| Child | 1 | 1990 | 7362 | 0.010 |
Why?
|
| Epithelium | 2 | 1989 | 315 | 0.010 |
Why?
|
| Forelimb | 1 | 1992 | 19 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1992 | 125 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 242 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1992 | 118 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 1991 | 34 | 0.010 |
Why?
|
| Veins | 1 | 1992 | 87 | 0.010 |
Why?
|
| Palmitates | 1 | 1991 | 17 | 0.010 |
Why?
|
| Carnitine | 1 | 1991 | 14 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1992 | 241 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1991 | 91 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1993 | 313 | 0.010 |
Why?
|
| Triglycerides | 1 | 1991 | 231 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1990 | 17 | 0.010 |
Why?
|
| Dogs | 1 | 1992 | 634 | 0.010 |
Why?
|
| Aspirin | 1 | 1992 | 167 | 0.010 |
Why?
|
| Muscles | 1 | 1991 | 184 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 367 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 433 | 0.000 |
Why?
|
| Ki-1 Antigen | 1 | 1990 | 19 | 0.000 |
Why?
|
| Karyotyping | 1 | 1990 | 222 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 410 | 0.000 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1990 | 232 | 0.000 |
Why?
|
| Cholesterol | 1 | 1991 | 364 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 1014 | 0.000 |
Why?
|
| Metaplasia | 1 | 1989 | 40 | 0.000 |
Why?
|
| Cell Division | 1 | 1990 | 690 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1990 | 476 | 0.000 |
Why?
|
| Ulcer | 1 | 1988 | 38 | 0.000 |
Why?
|
| Base Sequence | 1 | 1991 | 2209 | 0.000 |
Why?
|
| Myocardium | 1 | 1991 | 570 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1990 | 661 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1988 | 91 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1990 | 752 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1991 | 2889 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 1449 | 0.000 |
Why?
|
| Gastroesophageal Reflux | 1 | 1988 | 121 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1992 | 835 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1992 | 1123 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1991 | 2020 | 0.000 |
Why?
|
| Infant | 1 | 1991 | 3220 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 1991 | 1194 | 0.000 |
Why?
|
| Phenotype | 1 | 1990 | 2545 | 0.000 |
Why?
|
| Animals | 1 | 1992 | 28047 | 0.000 |
Why?
|